Health Benefits of Heat-Killed (Tyndallized) Probiotics: An Overview.
Piqué N, Berlanga M, Miñana-Galbis D. · 2019
Read Health Benefits of Heat-Killed (Tyndallized) Probiotics: An Overview. by Piqué N, Berlanga M, Miñana-Galbis D. (2019) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6566317.txt.
Introduction
Piqué, Berlanga and Miñana-Galbis survey the health effects of probiotics that are no longer alive, writing in the International Journal of Molecular Sciences. Live probiotics carry real, if uncommon, risks: bloodstream infections in fragile patients, transfer of antibiotic resistance genes, and interference with newborn gut colonization. Heat-killed, or tyndallized, bacteria sidestep those hazards entirely.
Dead cells cannot reproduce, yet their walls and fragments still talk to the immune system. The review gathers evidence for calmer gut inflammation, better barrier integrity and defense against gut pathogens. Products built on killed strains already serve in bloating, infant colic and diarrhea care, with hints of benefit in allergic skin and airway disease. The authors frame them as the safer branch of probiotic practice.
Catalog record
| CREATOR | Piqué N, Berlanga M, Miñana-Galbis D. |
|---|---|
| YEAR | 2019 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 115 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Health Benefits of Heat-Killed (Tyndallized) Probiotics: An Overview By Núria Piqué, Mercedes Berlanga, David Miñana-Galbis Published in: International Journal of Molecular Sciences DOI: 10.3390/ijms20102534 ABSTRACT Abstract Nowadays, the oral use of probiotics is widespread. However, the safety profile with the use of live probiotics is still a matter of debate. Main risks include: Cases of systemic infections due to translocation, particularly in vulnerable patients and pediatric populations; acquisition of antibiotic resistance genes; or interference with gut colonization in neonates. To avoid these risks, there is an increasing interest in non-viable microorganisms or microbial cell extracts to be used as probiotics, mainly heat-killed (including tyndallized) probiotic bacteria (lactic acid bacteria and bifidobacteria). Heat-treated probiotic cells, cell-free supernatants, and purified key components are able to confer beneficial effects, mainly immunomodulatory effects, protection against enteropathogens, and maintenance of intestinal barrier integrity. At the clinical level, products containing tyndallized probiotic strains have had a role in gastrointestinal diseases, including bloating and infantile coli—in combination with mucosal protectors—and diarrhea. Heat-inactivated probiotics could also have a role in the management of dermatological or respiratory allergic diseases. The reviewed data indicate that heat-killed bacteria or their fractions or purified components have key probiotic effects, with advantages versus live probiotics (mainly their safety profile), positioning them as interesting strategies for the management of common prevalent conditions in a wide variety of patients´ characteristics. Keywords: probiotics, heat-killed, tyndallized, Lactobacillus, Bifidobacterium, immunomodulatory 1. INTRODUCTION Currently, there is no doubt that the influence of the intestinal state on the health is gaining great interest, not only among the scientific community [1,2,3,4], but also for patients and consumers who are willing to adapt their diet habits to achieve the best well-being and health, besides other animal- or environment-related motives [5]. In this regard, gut microbiota, defined as a complex and dynamic microbiome containing more than 1000 different species, characteristic for each gastrointestinal (GI) tract segment, is recognized to be indispensable for homeostatic physiological functions in human health [1,3] at both the intestinal and extra-intestinal levels. With the advent of new sequencing technologies, mainly based on the 16S ribosomal RNA genes, and the development of sophisticated bioinformatic tools, characterization of gut microbiota is being advanced, leading to the understanding of the composition and function of bacterial populations throughout the intestine and to the influence of fluctuations in the diversity of gut bacterial populations (known as dysbiosis) in the development of diseases [1,4,6,7]. This knowledge has been translated in a great interest in those therapeutical strategies to directly or indirectly influence gut microbiota to obtain clinical benefits, such as the use of probiotics, prebiotics, and other food supplements or fecal transplantations [8,9,10]. Probiotics, according to the revised definition of Food and Agriculture Organization (FAO)/World Health Organization (WHO, are considered as non-pathogenic live microorganisms that, when administered in adequate amounts, confer a health benefit on the host. Now probiotics are widely used in many countries in clinical practice and, frequently, are acquired by consumers with or without prescription [9,11,12,13,14]. In most cases, probiotics, mainly strains of Bifidobacterium or Lactobacillus species, come from the gut microbiota of healthy humans or from dairy products [15]. Probiotics also include species from the genera Streptococcus, Bacillus, and Enterococcus and the yeast Saccharomyces, which has been used as probiotics for many years [11,16,17]. Among the main effects of probiotics at the intestinal level, the following are noteworthy: Balancing and restoration of the gut microbiota, protection against pathogens, immunomodulation, and maintenance of intestinal barrier integrity [18]. Probiotics are widely used in dietary supplements, food, infant formula formulations, and medical devices [19,20]. They have demonstrated significant potential as therapeutic options for a variety of diseases, mainly gastrointestinal diseases (including acute infectious diarrhea, antibiotic-associated diarrhea, ulcerative colitis, irritable bowel syndrome, functional gastrointestinal disorders, or necrotizing enterocolitis), but also extra-intestinal disorders, such as hepatic encephalopathy [9,21]. However, there are still many issues on the table, for example, safety issues with the use of live microorganisms particularly in vulnerable populations [14,22,23,24], the lack of clear clinical recommendations in each specific clinical situation [9,21], the lack of compelling evidence from clinical trials for certain indications [8], the limited regulation of probiotics [20], or the lack of studies assessing the viability of microorganisms once in the intestine and the differences between viable or non-viable microorganisms [25]. In a recent survey on probiotic-prescribing practices among health care providers and review of current guidelines and published large clinical trials, it was concluded that recommendations appear to be inconsistent, non-specific, and, frequently, upon patient request. In a significant proportion, the choice of probiotic was left to the patient or the pharmacist. The three most common clinical indications for probiotics were prevention and treatment of antibiotic-related side effects and irritable bowel syndrome [21]. Moreover, safety issues with the use of live strains have been arisen in certain patient groups, such as neonates [11,26] and vulnerable patients [23], particularly due to translocation of bacteria from the gut to the systemic circulation, leading to an increased interest to use non-viable heat-killed probiotics [14,22,27]. There is considerable published evidence that preparations containing dead cells and their metabolites can also exert relevant biological responses, restoring the normal intestinal homeostasis, in many cases similar to that seen with live cells, although with potential differences [22,27]. After inactivation of bacteria, mainly by heat treatment, dead cells can release bacterial components with key immunomodulating effects and with antagonizing properties against pathogens. Different bacterial components, such as lipoteichoic acids, peptidoglycans, or exopolysaccharides (EPS), have been proposed to be mainly involved in these properties in preparations containing heat-killed bacteria [27,28,29]. Favorable properties of heat-killed bacteria have been observed in in vitro, animal models [27], and clinical trials [30,31], which have demonstrated their benefits in different indications, for example in neonates, without incurring the risks associated with live microorganisms [14,32], and with pharmaceutical advantages in terms of transport and storage (Table 1). [Table: Advantages of inactivated bacteria and/or purified compounds in comparison with live probiotics.] The objective of this article is to review the recent published studies indicating that heat-killed bacteria with health benefits can be a safe and feasible strategy for the management of different diseases, mainly gastrointestinal disorders, focusing on the possible mechanisms of action involved, in comparison with live strains. 2. BENEFICIAL EFFECTS OF PROBIOTICS The most extensively-studied and widely-used probiotic bacteria are Lactobacillus and Bifidobacterium [14,33,34,35]. Species of these two genera (including Bifidobacterium breve, Bifidobacterium longum, Lactobactillus fermentum, Lactobacillus plantarum, Lactobacillus casei or Lactobacillus rhamnosus) naturally inhabit the human gastrointestinal tract, and are thought to play pivotal roles in maintaining human health [34,36]. Therefore, the oral administration of probiotics is thought to reinforce the physiological functions of gut microbiota at the intestinal level. Probiotics are able to fight against pathogens by producing antimicrobial compounds and decreasing pH (with lactic acid production), and competing with pathogens for adhesion and colonization, and for nutrients and other growth factors in the gut [35], and suppressing the growth of pathogenic bacteria by directly binding to Gram-negative bacteria [9,19] (Figure 1). [Figure: Main mechanisms of action of probiotics [19].] Moreover, a body of evidence demonstrates that probiotic bacteria have immunomodulating properties, regulate inflammation in a number of ways, and enhance the epithelial barrier function to prevent chronic inflammation in the gut [19,35]